Mizuho MedyLtd Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Fuminari Karakawa

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	47yrs
Eigendom CEO	36.7%
Management gemiddelde ambtstermijn	14.6yrs
Gemiddelde ambtstermijn bestuur	12.7yrs

Recente managementupdates

Recent updates

Mizuho Medy Co.,Ltd.'s (TSE:4595) Earnings Are Not Doing Enough For Some Investors

Aug 06

CEO

Fuminari Karakawa (79 yo)

47yrs

Tenure

Mr. Fuminari Karakawa founded MIZUHO MEDY Co., Ltd. in November 1977 and serves as its President and Representative Director since November 1977. Mr. Karakawa serves as the Chairman of the Board at MIZUHO...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Fuminari Karakawa	Chairman of the Board & President	47yrs	geen gegevens	36.69% ¥ 11.4b
Hiroshi Sasaki	GM of Accounting Department & General Affairs Department and Director	14.6yrs	geen gegevens	0.22% ¥ 67.1m
Toshio Kamihara	General Manager of Sales Division & Overseas Business Department and Director	9.7yrs	geen gegevens	0.074% ¥ 22.9m
Tadashi Imamura	MD, Technology Supervisor	no data	geen gegevens	0.43% ¥ 134.3m
Kazuhiro Ichimaru	Manager of Intellectual Property Department & Director	no data	geen gegevens	0.48% ¥ 149.6m
Kenji Narahara	Manager of Development Department and Director	no data	geen gegevens	0.54% ¥ 167.0m

14.6yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 4595 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 14.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Fuminari Karakawa	Chairman of the Board & President	47yrs	geen gegevens	36.69% ¥ 11.4b
Hiroshi Sasaki	GM of Accounting Department & General Affairs Department and Director	13.7yrs	geen gegevens	0.22% ¥ 67.1m
Toshio Kamihara	General Manager of Sales Division & Overseas Business Department and Director	9.7yrs	geen gegevens	0.074% ¥ 22.9m
Tadashi Imamura	MD, Technology Supervisor	14.7yrs	geen gegevens	0.43% ¥ 134.3m
Kazuhiro Ichimaru	Manager of Intellectual Property Department & Director	13.7yrs	geen gegevens	0.48% ¥ 149.6m
Kenji Narahara	Manager of Development Department and Director	11.7yrs	geen gegevens	0.54% ¥ 167.0m
Katsumi Sasaki	Independent External Director	9.7yrs	geen gegevens	0.028% ¥ 8.7m
Nobuhiko Shigemi	External Auditor	13.7yrs	geen gegevens	0.019% ¥ 6.0m
Takakichi Hashimoto	External Auditor	9.7yrs	geen gegevens	0.021% ¥ 6.4m
Hirotaka Kawasaki	Chairman of Board of Corporate Auditors	5.7yrs	geen gegevens	0.34% ¥ 105.6m

12.7yrs

Gemiddelde duur

64.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 4595 zijn ervaren en ervaren (gemiddelde ambtstermijn van 12.7 jaar).

Mizuho MedyLtd Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 28, 2024

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 29, 2023

No independent directors

No independent directors

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 30, 2022

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 26, 2021

Recent updates

Mizuho Medy Co.,Ltd. to Report Q3, 2024 Results on Nov 08, 2024

Second quarter 2024 earnings released: EPS: JP¥54.49 (vs JP¥75.07 in 2Q 2023)

Mizuho Medy Co.,Ltd.'s (TSE:4595) Earnings Are Not Doing Enough For Some Investors

Upcoming dividend of JP¥80.00 per share

Mizuho Medy Co.,Ltd. to Report Q2, 2024 Results on Aug 09, 2024

First quarter 2024 earnings released: EPS: JP¥102 (vs JP¥78.33 in 1Q 2023)

Mizuho Medy Co.,Ltd. to Report Q1, 2024 Results on May 10, 2024

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 28, 2024

Full year 2023 earnings released: EPS: JP¥396 (vs JP¥823 in FY 2022)

Now 21% undervalued

Inaugural dividend of JP¥140 per share

Mizuho Medy Co.,Ltd. to Report Q4, 2023 Results on Feb 09, 2024

Third quarter 2023 earnings released: EPS: JP¥143 (vs JP¥308 in 3Q 2022)

Investor sentiment improves as stock rises 16%

Mizuho Medy Co.,Ltd. to Report Q3, 2023 Results on Nov 10, 2023

Investor sentiment improves as stock rises 19%

Price target decreased by 23% to JP¥2,400

Second quarter 2023 earnings released: EPS: JP¥75.07 (vs JP¥135 in 2Q 2022)

Mizuho Medy Co.,Ltd. to Report Q2, 2023 Results on Aug 10, 2023

Inaugural dividend of JP¥40.00 per share

First quarter 2023 earnings released: EPS: JP¥78.33 (vs JP¥201 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥823 (vs JP¥506 in FY 2021)

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 29, 2023

Mizuho Medy Co.,Ltd. to Report Fiscal Year 2022 Results on Feb 10, 2023

Inaugural dividend of JP¥160 per share

Price target decreased to JP¥2,500

No independent directors

Third quarter 2022 earnings released: EPS: JP¥308 (vs JP¥187 in 3Q 2021)

Mizuho Medy Co.,Ltd. to Report Q3, 2022 Results on Nov 11, 2022

Second quarter 2022 earnings released: EPS: JP¥135 (vs JP¥173 in 2Q 2021)

Investor sentiment improved over the past week

Inaugural dividend of JP¥50.00 per share

Mizuho Medy Co.,Ltd. to Report Q2, 2022 Results on Aug 10, 2022

First quarter 2022 earnings released: EPS: JP¥201 (vs JP¥68.35 in 1Q 2021)

No independent directors

Mizuho Medy Co.,Ltd. to Report Q1, 2022 Results on May 09, 2022

Investor sentiment deteriorated over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 30, 2022

Inaugural dividend of JP¥95.00 per share

Third quarter 2021 earnings released: EPS JP¥187 (vs JP¥8.29 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥173 (vs JP¥9.45 loss in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS JP¥68.35 (vs JP¥0.32 loss in 1Q 2020)

Full year 2020 earnings released: EPS JP¥32.13 (vs JP¥91.76 in FY 2019)

Mizuho Medy Co.,Ltd. to Report Q1, 2021 Results on May 10, 2021

New 90-day high: JP¥2,653

Full year 2020 earnings released: EPS JP¥32.13 (vs JP¥91.76 in FY 2019)

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 26, 2021

Investor sentiment improved over the past week

New 90-day high: JP¥1,565

First Dividend Is JP¥6.00 Per Share

Mizuho Medy Co.,Ltd. to Report Fiscal Year 2020 Results on Feb 10, 2021

New 90-day low: JP¥1,307

Price target raised to JP¥1,500

Mizuho Medy Co.,Ltd. to Report Q3, 2020 Results on Nov 09, 2020

Mizuho Medy Co.,Ltd.(TSE:4595) dropped from S&P Global BMI Index

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd